Skip to search.
 FTSE 100 Down 0.93%

Edwards Lifesciences Corp. (EW)

-NYSE
105.92 Down 0.94(0.88%) 15:23 - Nasdaq Real Time Price
Prev Close:106.86
Open:106.09
Bid:106.38 x 200
Ask:106.50 x 200
1y Target Est:117.14
Beta:0.548154
Earnings Date:26 Jul - 1 Aug (Est.)
Day's Range:105.80 - 107.23
52wk Range:61.38 - 112.00
Volume:192,207
Avg Vol (3m):1,938,860
Market Cap:22.43b
P/E (ttm):47.08
EPS (ttm):2.25
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for EW at this time.

Comparison

Symbol% ChgMkt Cap
EWDown 0.88%22.43b
MDTDown 0.39%110.74b
STJDown 0.56%21.55b
ICUIDown 0.10%1.62b

Key Statistics

Forward P/E (1 yr):32.35
P/S (ttm):9.20
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :2.76
Quarterly EPS Est (Jun-16) :0.70
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):2.35

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Edwards Lifesciences Corporation provides products and technologies to treat structural heart disease and critically ill patients worldwide. It offers transcatheter heart valve therapy products comprising transcatheter aortic heart valves and thei... more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback